<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Exicure, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Exicure, Inc.

    Exicure, Inc. is a clinical stage biotechnology company developing a new class of immunomodulatory and gene regulating drugs against validated targets. Exicure's proprietary 3-dimensional, spherical nucleic acid (SNA™) architecture unlocks the potential of therapeutic oligonucleotides in a wide range of cells and tissues. Exicure's lead programs address oncology, inflammatory diseases and genetic disorders. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      David A. Giljohann
    • FOUNDED
      2009
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Ultragenyx Pharmaceutical Inc.

    Ultragenyx Pharmaceutical Inc.

    Ultragenyx is a biopharmaceutical company committed to bringing to patients novel ...

    Ultragenyx is a biopharmaceutical company commi...

    Filing Type:    PU
    Dynatronics Corporation

    Dynatronics Corporation

    Dynatronics is a leading medical device company committed to providing high-qualit...

    Dynatronics is a leading medical device company...

    Filing Type:    PU
    Phenomix Sciences LLC

    Phenomix Sciences LLC

    The objective of Phenomix Sciences, LLC (Phenomix) is to provide healthcare soluti...

    The objective of Phenomix Sciences, LLC (Phenom...

    Amount Raised:    $288,547.00
    Fundraising Status:    EC
    Filing Type:    CF
    Anavex Life Sciences Corp.

    Anavex Life Sciences Corp.

    Anavex utilizes precision genetic medicine to treat severe and devastating neurolo...

    Anavex utilizes precision genetic medicine to t...

    Filing Type:    PU
    Ionis Pharmaceuticals, Inc.

    Ionis Pharmaceuticals, Inc.

    Ionis is a sustainably profitable, multi-product company with a pipeline of more t...

    Ionis is a sustainably profitable, multi-produc...

    Filing Type:    PU
    Foamix Pharmaceuticals Ltd.

    Foamix Pharmaceuticals Ltd.

    Foamix Pharmaceuticals is a specialty pharmaceutical company, committed to address...

    Foamix Pharmaceuticals is a specialty pharmaceu...

    Filing Type:    PU
    NGM Biopharmaceuticals, Inc.

    NGM Biopharmaceuticals, Inc.

    We are a clinical stage biopharmaceutical company focused on harnessing powerful b...

    We are a clinical stage biopharmaceutical compa...

    Filing Type:    PU
    Aethlon Medical, Inc.

    Aethlon Medical, Inc.

    At Aethlon Medical, we are a leading developer of immunotherapeutic technologies t...

    At Aethlon Medical, we are a leading developer ...

    Filing Type:    PU
    UroGen Pharma Ltd.

    UroGen Pharma Ltd.

    UroGen Pharma Ltd. is a clinical-stage biopharmaceutical company developing advanc...

    UroGen Pharma Ltd. is a clinical-stage biopharm...

    Filing Type:    PU
    Enlivex Therapeutics Ltd.

    Enlivex Therapeutics Ltd.

    Enlivex is a clinical stage immunotherapy company, developing an allogeneic drug p...

    Enlivex is a clinical stage immunotherapy compa...

    Filing Type:    PU
    Galapagos NV

    Galapagos NV

    Galapagos develops therapies with proprietary, novel modes-of-action. Filgotinib, ...

    Galapagos develops therapies with proprietary, ...

    Filing Type:    PU
    Immunic, Inc.

    Immunic, Inc.

    Immunic, Inc. (Nasdaq: IMUX) is a clinical-stage biopharmaceutical company develop...

    Immunic, Inc. (Nasdaq: IMUX) is a clinical-stag...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.